Virtus Biotech Clinical Trials ETF BBC · ETF Open Virtus Biotech Clinical Trials ETF in new tab
Weights
Sector Weights
Country Weights
United States
Netherlands
Canada
Ireland
United Kingdom
Switzerland
Germany
Singapore
China
Virtus Biotech Clinical Trials ETF Analysis (BBC)
Investment Objective: Virtus Biotech Clinical Trials ETF is an investment vehicle focused on the Financial Services sector in US. It is currently trading at 51.06 USD.
Portfolio Composition:
The fund is heavily weighted towards
the Healthcare sector (99%),
the Financial Services sector (1%),
the Cash & Others sector (0%)
and markets in
United States (89%),
Netherlands (3%),
Canada (2%)
.
For a full breakdown of all holdings, see the "Weights" card above.
Income: This is a distributing fund with a current yield of 1.47%.
Investor FAQ
Does Virtus Biotech Clinical Trials ETF pay a dividend?
Yes, it pays an annual dividend of 0.66 USD (1.47% yield).
What asset class is Virtus Biotech Clinical Trials ETF?
Virtus Biotech Clinical Trials ETF is classified as a ETF. You can compare it against its peer in the "Related Symbols" list.
Fund Strategy
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.
| Year | Total Dividends |
|---|---|
| ▸2026 |
1.92 USD
|
| Dec. 29, 2026 (estimated) | 1.9171 |
| ▸2025 |
0.66 USD
|
| Dec. 29, 2025 | 0.6550 |
| ▸2024 |
0.24 USD
|
| Dec. 27, 2024 | 0.2400 |
| ▸2023 |
0.08 USD
|
| Dec. 29, 2023 | 0.0820 |
| ▸2017 |
0.30 USD
|
| Dec. 27, 2017 | 0.2970 |
| ▸2015 |
0.15 USD
|
| Dec. 29, 2015 | 0.1470 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Virtus Biotech Clinical Trials ETF | Dec 29, 2025 | Paid | 0.655 USD |
Community Discussion